Clinical Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Children with Juvenile Myelomonocytic Leukemia: A Report from the Japan Society for Hematopoietic Cell Transplantation-Reference-Cited by-同舟云学术

Clinical Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Children with Juvenile Myelomonocytic Leukemia: A Report from the Japan Society for Hematopoietic Cell Transplantation

Published:2020-05 Issue:5 Volume:26 Page:902-910
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Yoshida Nao,Sakaguchi Hirotoshi,Yabe Miharu,Hasegawa Daiichiro,Hama Asahito,Hasegawa Daisuke^ORCID,Kato Motohiro,Noguchi Maiko,Terui Kiminori,Takahashi Yoshiyuki,Cho Yuko,Sato Maho,Koh Katsuyoshi,Kakuda Harumi,Shimada Hiroyuki,Hashii Yoshiko,Sato Atsushi,Kato Koji,Atsuta Yoshiko,Watanabe Kenichiro

Funder

Japan Agency for Medical Research and Development

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference38 articles.

1. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia;Arber;Blood,2016

2. Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors;Emanuel;Blood,1991

3. Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS);Niemeyer;Blood,1997

4. Mutations of the NF1 gene in children with juvenile myelomonocytic leukemia without clinical evidence of neurofibromatosis, type 1;Side;Blood,1998

5. RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML);Flotho;Leukemia,1999

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decitabine-based treatment strategy improved the outcome of HSCT in JMML: a retrospective cohort study;Frontiers in Immunology;2024-08-26

2. Droplet digital PCR: An effective method for monitoring and prognostic evaluation of minimal residual disease in JMML;British Journal of Haematology;2024-04-15

3. Allogeneic Hematopoietic Cell Transplantation for Juvenile Myelomonocytic Leukemia with a Busulfan, Fludarabine, and Melphalan Regimen: JPLSG JMML-11;Transplantation and Cellular Therapy;2024-01

4. A successful second allogeneic hematopoietic stem cell transplantation from an alternative donor in a patient with loss of HLA heterozygosity relapse of juvenile myelomonocytic leukemia: case series analysis;Pediatric Hematology/Oncology and Immunopathology;2023-09-30

5. Azacitidine (Vidaza®) in Pediatric Patients with Relapsed Advanced MDS and JMML: Results of a Phase I/II Study by the ITCC Consortium and the EWOG-MDS Group (Study ITCC-015);Pediatric Drugs;2023-09-11